Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.44 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.43 |
| ▸ | IDH1 | O75874 | 8/20 | 0.42 |
| ▸ | IDH2 | P48735 | 2/20 | 0.42 |
| ▸ | PGK1 | P00558 | 1/20 | 0.39 |
| ▸ | PGK2 | P07205 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.39 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.38 |
| ▸ | AHR | P35869 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29463867 | 1.00 | P2RX7 (0.44) | P2RX7NOTUMIDH1IDH2PGK1 | |
| SCHEMBL3295150 | 0.84 | P2RX7 (0.50) | P2RX7NOTUMIDH1IDH2PGK1 | |
| SCHEMBL10749077 | 0.81 | CYP3A4 (0.40) | P2RX7NOTUMPGK1PGK2 | |
| SCHEMBL17184335 | 0.78 | CYP3A4 (0.58) | P2RX7NOTUMPGK1PGK2 | |
| SCHEMBL16472119 | 0.78 | MAPT (0.35) | IDH1IDH2PGK1PGK2ADRB1 | |
| SCHEMBL2565469 | 0.78 | MAPT (0.35) | IDH1IDH2PGK1PGK2ADRB1 | |
| SCHEMBL30395354 | 0.77 | NOTUM (0.58) | P2RX7NOTUMIDH1IDH2GABRA1 | |
| SCHEMBL15624402 | 0.77 | NOTUM (0.58) | P2RX7NOTUMIDH1IDH2GABRA1 | |
| SCHEMBL19072762 | 0.75 | NOTUM (0.47) | NOTUMIDH1IDH2GABRA1GABRG2 | |
| SCHEMBL3525189 | 0.75 | PGK1 (0.31) | PGK1PGK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114361590-B | Electrolyte additive for lithium ion battery, electrolyte and lithium ion battery | 松山湖材料实验室 | 2023-07-25 | — | — | CN | claimed |
| CN-109988101-B | Synthesis method of 2-fluoro-6-trifluoromethylpyridine | 沈阳化工研究院有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-114361590-A | Lithium ion battery electrolyte additive, electrolyte and lithium ion battery | 松山湖材料实验室 | 2022-04-15 | — | — | CN | claimed |
| CN-109988101-A | The synthetic method of the fluoro- 6- trifluoromethyl pyridine of 2- | 沈阳化工研究院有限公司 | 2019-07-09 | — | — | CN | claimed |
| CN-106316933-A | Continuous preparation method for 2-fluoro-6-trifluoromethyl pyridine | 大连九信精细化工有限公司 | 2017-01-11 | — | — | CN | claimed |
| WO-2015151116-A2 | PROCESS FOR PRODUCING 2-FLUORO-6-(TRIFLUOROMETHYL)PYRIDINE COMPOUNDS | JUBILANT LIFE SCIENCES LIMITED (IN) | 2015-10-08 | — | — | WO | claimed |
| EP-1109788-B1 | CHEMICAL PROCESS FOR PREPARING 2-HYDROXY-6-TRIFLUOROMETHYLPYRIDINE | SYNGENTA LTD (GB) | 2004-01-28 | — | — | EP | claimed |
| EP-1109788-A1 | CHEMICAL PROCESS FOR PREPARING 2-HYDROXY-6-TRIFLUOROMETHYLPYRIDINE | Syngenta Limited (GB) | 2001-06-27 | — | — | EP | claimed |
| US-6143899-A | REACTING 2-FLUORO-6-TRIFLUOROMETHYLPYRIDINE OR A MIXTURE OF 2-FLUORO-6-TRIFLUOROMETHYLPYRIDINE AND 2-CHLORO-6-TRIFLUOROMETHYLPYRIDINE WITH AN ALKALI METAL HYDROXIDE, HEATING AND ACIDIFYING THE PRODUCT FORMED | ZENECA LIMITED (GB) | 2000-11-07 | — | — | US | claimed |
| WO-2000014068-A1 | CHEMICAL PROCESS FOR PREPARING 2-HYDROXY-6-TRIFLUOROMETHYLPYRIDINE | SYNGENTA LIMITED (GB) | 2000-03-16 | — | — | WO | claimed |
| EP-4731623-A1 | CARBOLINE COMPOUNDS AND USE THEREOF | PTC Therapeutics, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| CN-224156658-U | Tubular reactor for absorbing tail gas of 2-fluoro-6-trifluoromethyl pyridine | 浙江方华化学有限公司 | 2026-04-24 | — | — | CN | disclosed |
| CN-224156658-U | Tubular reactor for absorbing tail gas of 2-fluoro-6-trifluoromethyl pyridine | 浙江方华化学有限公司 | 2026-04-24 | — | — | CN | disclosed |
| EP-4717266-A2 | OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS | Corcept Therapeutics Incorporated (US) | 2026-04-01 | — | — | EP | disclosed |
| US-20260083851-A1 | POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS | AVILAR THERAPEUTICS, INC. (US) | 2026-03-26 | — | — | US | disclosed |
| WO-2000014068-A1 | CHEMICAL PROCESS FOR PREPARING 2-HYDROXY-6-TRIFLUOROMETHYLPYRIDINE | SYNGENTA LIMITED (GB) | 2000-03-16 | — | — | WO | disclosed |
| WO-2000014068-A1 | CHEMICAL PROCESS FOR PREPARING 2-HYDROXY-6-TRIFLUOROMETHYLPYRIDINE | SYNGENTA LIMITED (GB) | 2000-03-16 | — | — | WO | disclosed |
| CN-1201032-A | Herbicidal 3,5-difluoropyridine | AMERICA CYANIDE CO (US) | 1998-12-09 | — | — | CN | disclosed |
| US-4474599-A | 1-(Pyridyl)-1H-1,2,3-triazole derivatives, and use as herbicidal agents | THE DOW CHEMICAL COMPANY (US) | 1984-10-02 | — | — | US | disclosed |
| US-4203988-A | ANTISECRETORY AGENTS | MERCK & CO., INC. (US) | 1980-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260083851-A1 | POTENT ASGPR-BINDING HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS | ASGR1, FCGR2A, FCGR3B | P2RX7 1807/4885NOTUM 1938/4885IDH1 3530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.